By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys reported late on Tuesday that revenues for the first quarter rose 66 percent.

The San Diego-based software solutions firm said that for the three months ended March 31, it posted $34.6 million in revenues, up from $20.8 million a year ago. Revenues for the quarter included $4 million in content revenue, related to databases that it acquired when it merged with Symyx during the summer. Accelrys had no content revenue in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.